121 – 130 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy
(
- Contribution to journal › Article
-
Mark
Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)
(
- Contribution to journal › Article
-
Mark
High sustained response rate in patients with histologically mild (low grade and stage) chronic hepatitis C infection. A randomized, double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin.
(
- Contribution to journal › Article
-
Mark
Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
(
- Contribution to journal › Article
- 2001
-
Mark
Short and long term outcome of severe acute pancreatitis.
(
- Contribution to journal › Article
-
Mark
GB virus C/hepatitis G virus infection in patients investigated for chronic liver disease and in the general population in southern Sweden
(
- Contribution to journal › Article
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article
- 2000
-
Mark
Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population
(
- Contribution to journal › Article
-
Mark
Alpha1-antitrypsin deficiency (PiZ) may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infection
(
- Contribution to journal › Article
-
Mark
Pravastatin down-regulates inflammatory mediators in human monocytes in vitro
(
- Contribution to journal › Article